Abstract
Disease, disability, and death from cardiovascular disease (CVD) represent major problems in the elderly. As the elderly population continues to grow and constitute a larger proportion of the general population, the magnitude of the problem is expected to increase and to place a heavy burden on existing medical care resources. Heart disease and stroke continue to be the first and third leading causes of death in the United States, respectively. CVD becomes the leading cause of death by age 40 years, whereas in women this is delayed until age 70 years, accounting for the predominance of women in the elderly population (1).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
National Institutes of Health and National Heart, Lung, and Blood Institute. Chartbook on Cardiovascular, Lung and Blood Disease. Washington, DC: US Dept of Health and Human Services, Public Health Services.
Kannel WB, Abbott RD. Incidence and prognosis of unrecognized myocardial infarctions: An update from the Framingham Study. N Engl J Med 1984;34:1144–1147.
Kannel WB, Wolf PA, Garrison RJ. The Framingham Study, Section 34: Some Risk Factors Related to the Incidence of Cardiovascular Disease and Death Using Pooled Repeated Biennial Measurements; Framingham Heart Study, 30-year Follow-up. Bethesda, MD: National Heart, Lung, and Blood Institute; 1987. NIH Publication 87-2703.
Kannel WB, D’Agostino RB. The importance of cardiovascular risk factors in the elderly. Am J Geriatr Cardiol 1995;2:10–23.
Centers for Disease Control and Prevention. National Center for Health Statistics Third National Health and Nutrition Examination Survey. 1988–1991.
Dannenberg AL, Garrison RJ, Kannel WB. Incidence of hypertension in the Framingham Study. Am J Public Health 1988;78:676–679.
Leitschuh M, Cupples LA, Kannel WB, et al. High-normal blood pressure progression to hypertension in the Framingham Heart Study. Hypertension 1991; 17:22–27.
Vasan RS, Larson MG, Leip EC, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001;358:1682–1686.
Wood D, DeBacker G, Faergeman O, Graham I, Mancia G, Pyorala K. Prevention of coronary heart disease in clinical practice: summary of recommendations of the second joint task force of European and other societies on coronary prevention. J Hypertens 1998;16:1407–1414.
Kannel WB, Dannenberg AL, Abbott RD. Unrecognized myocardial infarction and hypertension: the Framingham Study. Am Heart J 1985;109:581–585.
Verdecchia P, Carini G, Circo A, et al. Left ventricular mass and cardiovascular morbidity in essential hypertension. The MAVI Study. J Am Coll Cardiol 2001;38:1829–1835.
Kannel WB. Vital epidemiologic clues in heart failure. J Clin Epidemiol 2000;53:229–235.
Pannier B, Brunel P, Aroussey WE, et al. Pulse pressure and echocardiographic findings in essential hypertension. J Hypertens 1989;7:127–132.
Garden JM, Gottdiener JS, Wong ND, et al. Left ventricular mass in the elderly. The Cardiovascular Health Study. Hypertension 1997;29:1095–1103.
Post W, Larson MG, Levy D. Impact of left ventricular structure on the incidence of hypertension. The Framingham Heart Study. Circulation 1994;90:179–185.
Davidman M, Opsahl J. Mechanisms of elevated blood pressure in human essential hypertension. Med Clin North Am 1984;68:301–320.
Hachamovich R, Sonnenblick EH, Strom JA, Frishman WH. Left ventricular hypertrophy in hypertension, and the effects of antihypertensive drug therapy. Curr Probl Cardiol 1988;13:375–421.
Seshardri S, Wolf PA, Beiser A, et al. Elevated mid-life blood pressure increases stroke risk in elderly persons. The Framingham Study. Arch Intern Med 2001; 161: 2343–2350.
Rutan G, McDonald RH, Kuller LH. A historical perspective of systolic vs diastolic blood pressure from an epidemiological and clinical trial viewpoint. J Clin Epidemiol 1989;42:663–673.
Franklin SS, Kahn SA, Wong ND, Larson MG, Levy D. Is pulse pressure useful for predicting coronary disease? The Framingham Heart Study. Circulation 1999; 100: 253–360.
Franklin SS, Larson MG, Kahn SA, et al. Does the relation of blood pressure to coronary heart disease change with aging? Circulation 2001; 103:1245–1249.
Madhaven S, Ooi WL, Cohen H, Alderman MH. Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertension 1994;23:395–401.
Chae CU, Pfeffer MA, Glynn RJ, Mitchell GF, Taylor JO, Hennekens CH. Increased pulse pressure and risk of heart failure in the elderly. JAMA 1999;281:634–639.
Psaty BM, Furberg CD, Kuller LH, et al. Association between blood pressure level and the risk of myocardial infarction, stroke and total mortality. The Cardiovascular Health Study. Arch Intern Med 2001; 161:1183–1192.
Lloyd-Jones DM, Evans JC, Larson MG, O’Donnel CJ, Levy D. Differential impact of systolic and diastolic blood pressure on JNC-VI staging. Hypertension 1999;34:381–385.
Kannel WB, Wilson PWF, Silbershatz H. D’Agostino RB. Epidemiology of risk factor clustering in elevated blood pressure. In: Gotto AM, Lenfant C, Paoletti R, Eds. Multiple Risk Factors in Cardiovascular Disease. Dordrecht, The Netherlands: Kluwer Academic Publishers and Fondazione Giovanni Lorenzini; 1998:325–333.
Reaven GM. Insulin resistance, hyperinsulinemia, and hypertriglyceridemia in the etiology clinical course of hypertension. Am J Med 1991;90:7S–12S.
Anderson KM, Odell PM, Wilson PWF, Kannel WB. Cardiovascular disease risk profiles. Am Heart J 1990;121:293–298.
Moore MA, Epstein M, Agoda L, Dwarkin LD. Current strategies for management of hypertensive renal disease. Arch Intern Med 1999;159:23–28.
Mimran A. Microalbuminuria in essential hypertension. Clin Exp Hypertens 1997;19:23–28.
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure JNC 7. JAMA2003;289:2560–2572.
SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1991;265:3255–3264.
Staessen JA, Fagard R, Thijs L, et al. Randomized double blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997;350:757–764.
Berlowitz DR, Ash AS, Hickey EC, et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med 1998;339:1957–1963.
Coppola WG, Whincup PH, Walker M, Ebrahim S. Identification and management of stroke risk in older people: a national survey of current practice in primary care. J Hum Hypertens 1997;11:185–191.
Kannel WB. Prospects for prevention of cardiovascular disease in the elderly. Prev Cardiol 1998;1:32–39.
Madhavan S, Ooi WL, Cohen H, Alderman MH. Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertension 1994;23:395–401.
Wolf PA, D’Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham study. Stroke 1991;22:312–318.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Kannel, W.B., Wilson, P.W.F. (2005). Epidemiology of Hypertension in the Older Patient. In: Prisant, L.M. (eds) Hypertension in the Elderly. Clinical Hypertension and Vascular Diseases. Humana Press. https://doi.org/10.1007/978-1-59259-911-0_5
Download citation
DOI: https://doi.org/10.1007/978-1-59259-911-0_5
Publisher Name: Humana Press
Print ISBN: 978-1-58829-197-4
Online ISBN: 978-1-59259-911-0
eBook Packages: MedicineMedicine (R0)